GENE ONLINE|News &
Opinion
Blog

Funding
These Pharma Companies Are Laying Off Employees Due to Restructuring
2022-06-30
US Bio-Entrepreneur Program Launches in the UK
2022-06-30
Saudi Arabia to Invest $3.4 Billion in Latest Push to Develop Biotechnology Presence
2022-06-29
UK Launches World-First Program With Two Antimicrobial Drugs to Counter Superbugs
2022-06-16
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Kriya Bags $270 Million Series C to Support Integrated Gene Therapies
2022-05-18
BIO CEO 2022: How Incubators Enable Biotech Startups
2022-03-01
Aanika Bioscience Raises Fresh Capital to Scale Its Microbial “Tags” Technology Platform
2021-12-01
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
South Korea’s D&D Pharmatech Secures $51M Series C, Eyes 2022 IPO
2021-10-20
Axial Therapeutics to Advance Pipeline for Neurological Diseases with $37.25 Million Series C Funding
2021-10-17
1 2
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
Scroll to Top